CAR-Based Immunotherapy for Liver Cancer: A Bibliometric Atlas from 2016-2025

5,210 publications on chimeric antigen receptor (CAR) therapy for hepatocellular carcinoma were analyzed from Web of Science and Scopus. Hao Ying authored this data-driven atlas, which was last updated on April 22, 2026. The analysis reveals a sharp increase in research output since 2019, with China leading global contributions.

Use Cases

• Analyze publication trends and growth in CAR-based immunotherapy research based on the 5,210 included records.
• Map collaboration networks among authors and institutions based on the described network analysis.
• Identify shifts in research hotspots, such as the move toward gene regulation and the tumor microenvironment.
• Assess the geographic distribution of influential research, noting China's leading role.

Strengths

• Includes 5,210 publications, providing a substantial corpus for analysis.
• Covers a defined time range from 2016 to 2025, allowing for trend analysis.
• Uses systematic data collection from two major academic databases (Web of Science and Scopus).
• Clear license (CC-BY-4.0) permitting reuse with attribution.

Limitations

• The dataset is a 21.9 KB DOCX file, suggesting limited raw data and likely a summary document.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for quantitative analysis.

Provenance

Source

Systematic search of Web of Science Core Collection and Scopus databases.

Collection Method

Literature search conducted on September 30, 2025, with data-driven analysis performed using CiteSpace, VOSviewer, Excel, and R.

Time Range

Publications from 2016 to 2025.

Freshness

Last updated 2026-04-22 05:49:28; freshness should be verified.

Geography

Global, with noted concentration of research leadership in China.